Evaluation of apolipoprotein A2 isoforms and discovery of disease biomarkers by multi-omics study in population of medical checkups

Evaluation of apolipoprotein A2 isoforms and discovery of disease biomarkers by multi-omics study in population of medical checkups - Evaluation of apolipoprotein A2 isoforms in medical checkups

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025857

Enrollment

20000

Registered

2017-01-26

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: over 20 years old

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Positive predictive value of apolipoprotein AII isoforms for pancreatic cancer and its risk diseases in cancer screening	—

Secondary

Measure	Time frame
Correlation between the value of apolipoprotein AII isoforms and the clinical background factors	—

Countries

Japan

Contacts

Public ContactTakashi Kobayashi

Kobe university gastroenterology

kobatak@med.kobe-u.ac.jp078-382-6305

Outcome results